NASDAQ : BIOA
BioAge Labs, Inc. — Financial statements
Healthcare · Drug Manufacturers - Specialty & Generic · United States
Last price 5.94 USD (Oct 29, 2026, 4:00 PM EDT) · Market cap 272.63M
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Financial statements
BioAge Labs, Inc. (BIOA) reported revenue of 10.36M USD (TTM). Five years of income statement, balance sheet, cash flow and ratios below.
Income statement
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | |
|---|---|---|---|---|---|
| Revenue | 10.36M | 8.99M | |||
| Cost of Revenue | 87.79M | 73.97M | 59.04M | 33.89M | |
| Gross Profit | -77.43M | -64.97M | -59.04M | -33.89M | |
| Selling, General & Admin | 28.84M | 27.81M | 19.16M | 14.51M | 9.45M |
| Research & Development | 30.52M | ||||
| Operating Expenses | 28.84M | 27.81M | 19.16M | 14.51M | 39.97M |
| Operating Income | -106.27M | -92.78M | -78.19M | -48.40M | -39.97M |
| Interest Expense | -281.00K | -697.00K | -2.37M | -7.79M | -241.00K |
| Interest & Investment Income | 12.66M | 13.09M | 9.63M | 2.43M | 465.00K |
| Other Non Operating Income (Expenses) | -570.00K | -214.00K | 73.00K | ||
| EBT Excluding Unusual Items | -94.46M | -80.61M | -70.86M | -53.76M | -39.74M |
| Other Unusual Items | -250.00K | -10.09M | 23.00K | ||
| Pretax Income | -94.46M | -80.61M | -71.11M | -63.85M | -39.72M |
| Net Income | -94.46M | -80.61M | -71.11M | -63.85M | -39.72M |
| Net Income to Common | -94.46M | -80.61M | -71.11M | -63.85M | -39.72M |
| Shares Outstanding (Basic) | 39.84M | 35.93M | 10.73M | 1.67M | 1.67M |
| Shares Outstanding (Diluted) | 39.84M | 35.93M | 10.73M | 1.67M | 1.67M |
| EPS (Basic) | -2.37 | -2.24 | -6.63 | -38.17 | -23.76 |
| EPS (Diluted) | -2.37 | -2.24 | -6.63 | -38.17 | -23.76 |
| Free Cash Flow | -88.09M | -82.35M | -51.89M | -37.53M | -36.28M |
| Free Cash Flow Per Share | -2.21 | -2.29 | -4.84 | -22.43 | -21.70 |
| Operating Margin | -1,026.28% | -1,031.46% | |||
| Profit Margin | -912.25% | -896.11% | |||
| Free Cash Flow Margin | -850.69% | -915.46% | |||
| EBITDA | -106.02M | -92.57M | -78.03M | -48.24M | -39.84M |
| D&A For EBITDA | 251.00K | 213.00K | 167.00K | 162.00K | 129.00K |
| EBIT | -106.27M | -92.78M | -78.19M | -48.40M | -39.97M |
Balance sheet
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | |
|---|---|---|---|---|---|
| Cash & Equivalents | 73.96M | 188.89M | 354.35M | 21.64M | 27.64M |
| Short-Term Investments | 244.78M | 92.21M | |||
| Cash & Short-Term Investments | 318.75M | 281.10M | 354.35M | 21.64M | 27.64M |
| Accounts Receivable | 625.00K | 769.00K | |||
| Other Receivables | 2.50M | 1.20M | 1.20M | ||
| Receivables | 3.12M | 1.97M | 1.20M | ||
| Prepaid Expenses | 8.44M | 3.73M | 1.55M | 349.00K | 386.00K |
| Restricted Cash | 3.31M | ||||
| Total Current Assets | 330.31M | 286.79M | 357.10M | 25.31M | 28.03M |
| Property, Plant & Equipment | 3.79M | 3.75M | 791.00K | 518.00K | 374.00K |
| Long-Term Investments | 62.62M | 4.13M | 100.00K | 100.00K | |
| Other Long-Term Assets | 208.00K | 216.00K | 240.00K | 25.00K | |
| Total Assets | 396.93M | 294.89M | 358.23M | 25.92M | 28.43M |
| Accounts Payable | 5.65M | 2.67M | 2.00M | 1.87M | 2.26M |
| Accrued Expenses | 8.10M | 7.96M | 11.33M | 6.55M | 3.36M |
| Short-Term Debt | 38.86M | ||||
| Current Portion of Long-Term Debt | 2.65M | 6.00M | 6.00M | 167.00K | |
| Current Portion of Leases | 714.00K | 582.00K | 202.00K | 194.00K | 49.00K |
| Current Unearned Revenue | 4.36M | 5.75M | 7.83M | 3.31M | |
| Other Current Liabilities | 388.00K | 525.00K | 417.00K | 1.39M | 24.00K |
| Total Current Liabilities | 19.22M | 20.14M | 27.77M | 58.17M | 5.86M |
| Long-Term Debt | 2.50M | 8.20M | 2.25M | ||
| Long-Term Leases | 2.12M | 2.33M | |||
| Long-Term Unearned Revenue | 4.67M | ||||
| Other Long-Term Liabilities | 678.00K | 370.00K | 156.00K | 229.00K | 153.00K |
| Total Liabilities | 22.02M | 22.84M | 35.11M | 66.60M | 8.27M |
| Additional Paid-In Capital | 757.16M | 605.19M | 575.69M | 8.14M | 5.12M |
| Retained Earnings | -381.77M | -333.42M | -252.81M | -181.70M | -117.85M |
| Comprehensive Income & Other | -478.00K | 278.00K | 245.00K | 164.00K | 167.00K |
| Total Common Equity | 374.91M | 272.05M | 323.13M | -173.40M | -112.56M |
| Shareholders' Equity | 374.91M | 272.05M | 323.13M | -40.67M | 20.16M |
| Total Liabilities & Equity | 396.93M | 294.89M | 358.23M | 25.92M | 28.43M |
| Total Debt | 2.83M | 5.56M | 8.70M | 53.25M | 2.47M |
| Net Cash (Debt) | 378.43M | 279.57M | 345.64M | -31.61M | 25.18M |
| Net Cash Per Share | 9.50 | 7.78 | 32.22 | -18.90 | 15.06 |
| Filing Date Shares Outstanding | 45.90M | 44.38M | 35.85M | 1.67M | 1.67M |
| Total Common Shares Outstanding | 45.78M | 37.39M | 35.85M | 1.67M | 1.67M |
| Working Capital | 311.10M | 266.65M | 329.33M | -32.86M | 22.17M |
| Book Value Per Share | 8.19 | 7.28 | 9.01 | -103.62 | -67.33 |
| Tangible Book Value | 374.91M | 272.05M | 323.13M | -173.40M | -112.56M |
| Tangible Book Value Per Share | 8.19 | 7.28 | 9.01 | -103.62 | -67.33 |
| Machinery | 1.66M | 1.26M | 786.00K | 742.00K | 576.00K |
| Construction In Progress | 22.00K | 176.00K | |||
| Leasehold Improvements | 161.00K | 161.00K |
Cash flow statement
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | |
|---|---|---|---|---|---|
| Net Income | -94.46M | -80.61M | -71.11M | -63.85M | -39.72M |
| Depreciation & Amortization | 251.00K | 213.00K | 167.00K | 162.00K | 129.00K |
| Loss (Gain) From Sale of Assets | 23.00K | 23.00K | 55.00K | ||
| Stock-Based Compensation | 14.04M | 11.69M | 6.98M | 3.02M | 2.54M |
| Other Operating Activities | -1.76M | -1.12M | 1.21M | 16.60M | 77.00K |
| Change in Accounts Receivable | -22.00K | -769.00K | |||
| Change in Accounts Payable | 4.24M | 788.00K | 6.00K | -393.00K | 994.00K |
| Change in Unearned Revenue | -5.24M | -6.75M | 9.19M | 3.31M | |
| Change in Other Net Operating Assets | -4.67M | -5.10M | 1.98M | 3.79M | -199.00K |
| Operating Cash Flow | -87.60M | -81.63M | -51.52M | -37.36M | -36.18M |
| Capital Expenditures | -488.00K | -719.00K | -366.00K | -166.00K | -103.00K |
| Investment in Securities | -212.37M | -94.50M | -100.00K | ||
| Investing Cash Flow | -212.85M | -95.22M | -366.00K | -266.00K | -103.00K |
| Short-Term Debt Issued | 23.50M | ||||
| Long-Term Debt Issued | 12.50M | 2.50M | |||
| Total Debt Issued | 36.00M | 2.50M | |||
| Long-Term Debt Repaid | -6.00M | -6.00M | -1.00M | ||
| Net Debt Issued (Repaid) | -5.00M | -6.00M | -6.00M | 35.00M | 2.50M |
| Issuance of Common Stock | 161.22M | 17.87M | 222.25M | 4.00K | 44.00K |
| Other Financing Activities | -2.07M | -400.00K | -5.05M | -63.00K | -45.00K |
| Financing Cash Flow | 154.15M | 11.47M | 381.20M | 34.94M | 2.50M |
| Foreign Exchange Rate Adjustments | -61.00K | -87.00K | 81.00K | 246.00K | |
| Net Cash Flow | -146.37M | -165.46M | 329.39M | -2.69M | -33.54M |
| Free Cash Flow | -88.09M | -82.35M | -51.89M | -37.53M | -36.28M |
| Free Cash Flow Margin | -850.69% | -915.46% | |||
| Free Cash Flow Per Share | -2.21 | -2.29 | -4.84 | -22.43 | -21.70 |
| Levered Free Cash Flow | -58.07M | -54.84M | -34.21M | -27.91M | |
| Unlevered Free Cash Flow | -57.89M | -54.41M | -32.73M | -23.04M | |
| Cash Interest Paid | 264.00K | 611.00K | 1.42M | 1.16M | 129.00K |
| Change in Working Capital | -5.68M | -11.83M | 11.18M | 6.71M | 795.00K |
Ratios
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | |
|---|---|---|---|---|---|
| Market Capitalization | 269.41M | 474.36M | 207.56M | ||
| Enterprise Value | -109.01M | 185.64M | -116.70M | ||
| Last Close Price | 5.87 | 13.23 | 5.79 | ||
| PS Ratio | 26.02 | 52.74 | |||
| PB Ratio | 0.72 | 1.74 | 0.64 | ||
| P/TBV Ratio | 0.72 | 1.74 | 0.64 | ||
| EV/Sales Ratio | 20.64 | ||||
| Debt / Equity Ratio | 0.01 | 0.02 | 0.03 | -1.31 | 0.12 |
| Net Debt / Equity Ratio | -1.01 | -1.03 | -1.07 | -0.78 | -1.25 |
| Net Debt / EBITDA Ratio | 3.57 | 3.02 | 4.43 | -0.66 | 0.63 |
| Net Debt / FCF Ratio | 4.30 | 3.40 | 6.66 | -0.84 | 0.69 |
| Asset Turnover | 0.03 | 0.03 | |||
| Quick Ratio | 16.75 | 14.06 | 12.80 | 0.37 | 4.72 |
| Current Ratio | 17.19 | 14.24 | 12.86 | 0.43 | 4.78 |
| Return on Equity (ROE) | -28.21% | -27.09% | -50.35% | ||
| Return on Assets (ROA) | -18.47% | -17.76% | -25.44% | -111.31% | |
| Return on Capital Employed (ROCE) | -28.10% | -33.80% | -23.70% | 150.10% | -177.10% |
| Earnings Yield | -40.39% | -16.99% | -34.26% | ||
| FCF Yield | -32.70% | -17.36% | -25.00% | ||
| Buyback Yield / Dilution | -43.29% | -234.99% | -541.23% | -0.06% |